Samudi Raju Chandramathi, Kono Mari, Looi Kah Wai, Ong Jin Xu, Tan Chin Aun, Ang Chong Siang, Tan Peter Hao Yuan, Shamnugam Hemalatha, Sekaran Shamala Devi K C, Syed Omar Sharifah Faridah, Lum Lucy Chai See
Faculty of Medicine, Universiti Malaya, Wilayah Persekutuan, 50603, Kuala Lumpur, Malaysia.
R&D Centre Asia Pacific, Sysmex Asia Pacific, 9 Tampines Grande, Asia Green, #06-18, Singapore.
BMC Infect Dis. 2025 Apr 17;25(1):551. doi: 10.1186/s12879-025-10948-w.
Severe dengue has been linked to the presence of atypical lymphocytes, which can be quantified using the Q-flag parameter on a hematology analyzer. A higher atypical lymphocyte count has previously been associated with severe dengue. We aimed to evaluate the feasibility of the atypical lymphocyte score to provide an early prognosis for dengue severity.
A prospective observational study enrolled adult patients admitted to the Infectious Disease ward with a febrile illness of less than 7 days. Blood samples obtained daily until discharge, were processed with XN-20 hematology analyzer with specific attention given to atypical lymphocyte score. Severe dengue cases were classified according to the 2009 World Health Organization Classification.
A total of 287 cases of laboratory-confirmed dengue, including 25 severe cases, were included. Dengue fever compared to non-dengue patients manifested increased lymphocytes within the high fluorescent zone on Day 6, The atypical lymphocyte score (ALS) of severe dengue showed an early rise, reaching a saturation point of 300 and remaining stable within the timeframe of days 4 to 8 post-fever onset. All but one severe dengue patient had a score exceeding 100 on day 4 post fever onset.
An atypical lymphocyte score below 100 on day 4 post fever onset, may serve as a predictive indicator that severe dengue is less likely to develop, potentially allowing for a lower level of medical intervention. These findings may contribute to more efficient resource allocation during outbreaks.
The study was registered under National Medical Research Registration of Malaysia, (NMRR-18-3347-45473, 1 Sept 2019).
重症登革热与非典型淋巴细胞的存在有关,可使用血液分析仪上的Q-flag参数对其进行定量。此前,非典型淋巴细胞计数较高与重症登革热相关。我们旨在评估非典型淋巴细胞评分对登革热严重程度进行早期预后评估的可行性。
一项前瞻性观察性研究纳入了入住传染病病房、发热病程少于7天的成年患者。每天采集血样直至出院,使用XN-20血液分析仪进行检测,特别关注非典型淋巴细胞评分。重症登革热病例根据2009年世界卫生组织分类标准进行分类。
共纳入287例实验室确诊的登革热病例,其中包括25例重症病例。与非登革热患者相比,登革热患者在第6天高荧光区的淋巴细胞增多。重症登革热的非典型淋巴细胞评分(ALS)早期升高,在发热开始后的第4至8天达到300的饱和点并保持稳定。除1例重症登革热患者外,所有患者在发热开始后第4天的评分均超过100。
发热开始后第4天非典型淋巴细胞评分低于100,可能作为重症登革热不太可能发生的预测指标,从而可能降低医疗干预水平。这些发现可能有助于在疫情爆发期间更有效地分配资源。
该研究在马来西亚国家医学研究注册中心注册,(NMRR-18-3347-45473,2019年9月1日)。